Drug
Who makes insulin degludec?
2 companies list insulin degludec as a human prescription drug, including under the names Tresiba. Forms: injection, solution. Routes: subcutaneous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing insulin degludec
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Novo Nordisk Inc.Denmark | injection, solution | BLABLA203314 | 6 | 11 |
| International Medication Systems, Ltd.United States | injection, solution | BLABLA203314 | 4 | 3 |
Bulk ingredient listings
- Amphastar Nanjing Pharmaceuticals, Inc.China · 1 NDC
- Hefei Xinzhu Biological Technology Co Ltd.China · 1 NDC
Enquiry
Common questions
- Who makes insulin degludec?
- 2 companies list insulin degludec as a human prescription drug in the openFDA NDC Directory, led by Novo Nordisk Inc., International Medication Systems, Ltd.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies insulin degludec active ingredient?
- 2 companies list insulin degludec as a bulk ingredient, including Amphastar Nanjing Pharmaceuticals, Inc., Hefei Xinzhu Biological Technology Co Ltd..